logo
15:58 Jun 25

Procter & Gamble Health Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
6232.50
-15.50 (-0.25%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Procter & Gamble Health Ltd. Financials

Procter & Gamble Health Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
6232.50
-15.50 (-0.25%)
15:58 Jun 25
Quality
image/svg+xml

86/100
High Financial Strength

Valuation
image/svg+xml

36/100
Mid Valuation

Technical

58/100
Technically Neutral

Strength

13

Weakness

1

Opportunity

0

Threats

1

62.32 %

ROE %

38.85 %

ROA %

196.94

EPS

315.99

BVPS

0.00 %

Net Profit Margin

Jun 2022 Jun 2023 Jun 2024 Mar 2025 Mar 2026
Net Sales
1114.41 1229.62 1151.26 934.17 1407.97
Operating Expenses +
846.73 904.94 845.26 615.78 951.31
Raw Material
344.55 358.99 329.69 247.75 377.91
Increase Decrease in Cost
-4.75 2.85 0.87 14.75 -12.83
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
167.56 206.17 215.16 142.06 222.56
Miscellaneous Expenses
381.03 416.45 378.46 305.54 504.83
Operating Profit
267.68 324.68 306 318.39 456.66
Other Income
13.19 18.39 15.63 10.35 17.34
Depreciation
27.08 28.1 27.4 16.69 23.59
Interest
0.42 0.77 0.72 0.43 0.55
Profit before tax and exceptio..
253.37 314.2 293.51 311.62 449.86
Exceptional Items
0 0 -20.19 0 0
PBT
253.37 314.2 273.32 311.62 449.86
Provision for Taxation
60.85 84.73 72.34 77.21 122.95
Net Profit
192.52 229.47 200.98 234.41 326.91
NET Profit after MI
0 0 0 0 0
EPS
116 138 133 141 196.94
Operating Profit Margin (%)
24.02 26.4 26.58 34.08 32.43
Net Profit Margin (%)
17.28 18.66 17.46 25.09 23.22

Procter & Gamble Health Ltd. Shareholding

All Data in Percentage (%)
Promoter - - - - -
FII - - - - -
Public - - - - -
MF - - - - -
Others
Shareholder Shares Holding %
Research 360 logo
Download Our App On: